Rethinking the metastatic cascade as a therapeutic target.
about
Therapeutic Value of Voltage-Gated Sodium Channel Inhibitors in Breast, Colorectal, and Prostate Cancer: A Systematic ReviewTrespassing cancer cells: 'fingerprinting' invasive protrusions reveals metastatic culpritsTargeting and utilizing primary tumors as live vaccines: changing strategiesPG545, a heparan sulfate mimetic, reduces heparanase expression in vivo, blocks spontaneous metastases and enhances overall survival in the 4T1 breast carcinoma modelMolecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?Modulation of CD44 Activity by A6-PeptideLong-term nitric oxide exposure enhances lung cancer cell migrationCornering metastases: therapeutic targeting of circulating tumor cells and stem cells.Efficacy and Mechanisms of Aerobic Exercise on Cancer Initiation, Progression, and Metastasis: A Critical Systematic Review of In Vivo Preclinical DataWNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear β-Catenin depend on active PI3K signaling.Screening and Molecular Analysis of Single Circulating Tumor Cells Using Micromagnet Array.Molecular aspects of breast cancer metastasis to the brain.Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinomaPassive Entrapment of Tumor Cells Determines Metastatic Dissemination to Spinal Bone and Other Osseous Tissues.Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytesInvestigating dynamical deformations of tumor cells in circulation: predictions from a theoretical modelMiR-320e is a novel prognostic biomarker in colorectal cancer.p53 controls colorectal cancer cell invasion by inhibiting the NF-κB-mediated activation of FascinPhysical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotypePathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort.Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models.Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters.Inhibitions of several antineoplastic drugs on serum sialic Acid levels in mice bearing tumors.Postoperative simple biochemical markers for prediction of bone metastases in Egyptian breast cancer patients.MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4The identification and characterization of breast cancer CTCs competent for brain metastasis.Circulating Tumor Cells: When a Solid Tumor Meets a Fluid MicroenvironmentDifferential growth and responsiveness to cancer therapy of tumor cells in different environments.MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancerThe small GTPase ARF6 stimulates β-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis.Nordihydroguaiaretic acid impairs prostate cancer cell migration and tumor metastasis by suppressing neuropilin 1.MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8.IK channel activation increases tumor growth and induces differential behavioral responses in two breast epithelial cell lines.Means to the ends: The role of telomeres and telomere processing machinery in metastasis.The metastasis-associated molecule C4.4A promotes tissue invasion and anchorage independence by associating with the alpha6beta4 integrin.Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues.Efficacy of Cotargeting Angiopoietin-2 and the VEGF Pathway in the Adjuvant Postsurgical Setting for Early Breast, Colorectal, and Renal Cancers.
P2860
Q26772803-6226CE30-47FF-4783-A1E7-B3184F24FD2BQ26997307-ABCA8BA2-D537-4E0E-961C-F1A36584D543Q27009348-4BE7BA3C-BDCE-4742-9CE9-7DAD00D072F7Q27327191-076FACEA-B31F-45DE-8C4A-36F742814165Q28068956-BB2B5AEA-BF89-4B21-AD08-B20D923818C4Q28085166-558F611D-9942-486F-8011-3CBA51294093Q28387480-2285EE01-93B7-4900-BF4B-655E31D8652EQ30465825-A6033571-6FC8-4C20-B96C-80F1F07B70C8Q31112729-4DE26C2A-D800-4FF1-BD1C-969F5A76EA5BQ33917543-9B252233-AA65-4812-BCB1-3EDE4A42A692Q34500586-44780CFA-E38C-4D68-A176-5E8F92299BB4Q35909895-DB4F7F4F-B60A-4744-A3F1-CF33217D4BF7Q36092648-D4BC8B72-524F-4179-B55D-78F80E0925A1Q36125378-AFB7499D-D26E-499C-A634-5A163DD10394Q36210944-9A5A9105-1004-4092-8895-3B3E72D763E9Q36241042-3CF2853F-1ED2-4A90-80B1-D2C0C95DC55CQ36286673-CCAF4BA5-E1FA-44F4-AF8F-27E662BA229DQ36356097-39FFDB74-377A-430D-A3B1-F2B1F72E6A2CQ36419956-C07B8BB3-DCCC-4E82-BDA2-7A159A1ABD59Q36473001-009CEE1F-099A-4EAF-A93C-E3581F3C8A2EQ36557707-66901247-1FD6-4F74-AE81-3E6ACA3FACD2Q36607592-05E04271-2885-42B7-9F20-94486B1D4332Q36743402-D56CCC80-6DEF-4C3A-B65A-073BF0A45EDDQ36807447-2671A1DA-8A66-48A4-84AB-773DF473DC7EQ37092231-9B59EDC8-67B5-4C6F-A273-57C136C6EDC2Q37394096-43730A01-6E0C-41BC-89E6-40D17246C02EQ37420868-CDFEDF1B-EDEB-4484-BD76-F4EE6CEDE2E4Q37442859-AA5548D0-9B07-4AA1-B7F9-4CA1D09219ABQ37507386-8E5AC789-9A30-43E7-B793-382591E0F848Q37533025-D29CE5E5-16D4-445C-8DCB-DB26B66F154BQ37586913-06186B0D-BDD6-48CF-A260-A24DC9837B31Q37651978-A4F782CC-99A7-4EBC-8FBF-ADDB91FF8D4BQ37699218-0DD14058-C034-4148-9839-E381248E67D2Q37743883-0FE73347-6AC4-4385-A724-C7C5EEEF5E62Q38707271-2B2E775A-5E49-4AB5-802D-4608E5F8BDFFQ38987554-289E4C5A-0BBA-4307-A964-6E8A78A1CD9CQ39144970-CFD2B109-EBB6-4134-96C7-D323E4383AD7Q39408467-D88ED196-181B-447F-ABBB-7B333F0DF703Q41817665-25CACB98-26C4-4CCB-BD7C-9E1592CEC4DBQ42067472-9CD3A051-E8F4-47FE-9634-26311A487C40
P2860
Rethinking the metastatic cascade as a therapeutic target.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rethinking the metastatic cascade as a therapeutic target.
@en
Rethinking the metastatic cascade as a therapeutic target.
@nl
type
label
Rethinking the metastatic cascade as a therapeutic target.
@en
Rethinking the metastatic cascade as a therapeutic target.
@nl
prefLabel
Rethinking the metastatic cascade as a therapeutic target.
@en
Rethinking the metastatic cascade as a therapeutic target.
@nl
P2860
P1476
Rethinking the metastatic cascade as a therapeutic target.
@en
P2093
George W Sledge
Lida A Mina
P2860
P304
P356
10.1038/NRCLINONC.2011.59
P407
P577
2011-04-19T00:00:00Z